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Introduction
Our centre performed nearly 6000 genetic tests in 2011, in
11 genes, with a year on year increase of about 20% per
year over 5 years. In half of the patients genetic testing was
used as pre-screening before referral to clinic. A good
patient history is essential for proper diagnosis and treat-
ment of HRFS (hereditary recurrent fever syndromes), and
genetic testing is a more useful adjunct when guided by
relevant symptoms. In order to guide the testing strategy
and provide more helpful interpretation of results, we
asked the referring physicians to provide detailed informa-
tion on the patient’s family history, symptoms, etc. The
approach to collecting this information has evolved over
several years, and we describe our experience.
Objectives
To improve and streamline the collection of clinical data
for correlation with genetic test results.
Methods
Questions included description of family history, ethnic
origin, attack parameters, precipitants and age at onset, 13
symptom areas (including AA amyloidosis), measures of
acute phase response, and treatments, dose and effect s.
Initially (Stage 1) this information was elicited using a
paper proforma, designed to fit on a single side of A4
paper, and was filled in by the referring physician. These
were scanned into our records and were accessed as
needed, but the information contained could neither be
searched nor filtered, making finding correlations and
trends difficult. Later (Stage 2), the referring doctor could
access a web link, provided by us on request, and could
answer these questions online. The referring physician
selected answers from drop-down boxes, with an option
to write in some free text comments on the paper form to
accompany the specimen. Further refinement was added
in mid-2012 (Stage 3) with a web based approach, linked
directly from the Centre website to allow the referring
physician to request a test and answer the questions
immediately. More detailed questions particularly about
treatments were now included.
Results
Referring physicians were very cooperative but in Stage 1
often obtained forms well after the patient consultation,
meaning many useful details may have been omitted.
Initial impressions are that the smoother operation of the
web-based approach (Stage 2 and 3) is reflected in the
increasing use of the online submission method, and
seems particularly popular with non-UK referrals. The
specimen reception staff took over the operation of the
system with little need to consult with scarce IT staff, and
the data collected is easier to access and is searchable.
Negative feedback has been limited to a few problems
mainly with access local to the referring physicians.
Conclusion
Making the resulting data on the patient population
searchable simplified correlation of the information
provided with the genetic test findings, and has a immedi-
ate benefit of focussing scarce genetic testing resources
to where they are most likely to be useful. In the future,
technical advances may make genomic information much
more plentiful; the concurrent development of good symp-
tom curation using proper ontology will be an important
tool for diagnosing and treating HRFS.
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